Marken Announces Depot in Russia; Makes Senior Appointment
Marken announces a new depot in Russia and makes a senior appointment.
Marken, a provider of clinical-trial material supply solutions, has added a depot in Moscow as part of its global pharmaceutical depot network. The Russian depot will be located within an existing GxP-compliant storage facility in Moscow. The facility will be operated by staff trained on Marken’s global procedures and managed by the inventory system, Solo. It joins Marken’s current network of depots in China, Singapore, Argentina, Mexico, Germany, and the United States.
Marken’s network of pharmaceutical depot facilities and supporting IT systems are designed to provide storage and distribution of materials for clinical trials. They are designed for all clinical materials, including temperature-controlled and time-sensitive products.
In other news, Marken has appointed Michael Culme-Seymour as vice-president, Asia Pacific Region, effective Oct. 14, 2013. Culme-Seymour will be responsible for clinical logistics and Marken’s seven branches in the region, including: Singapore, Australia, India, China, Japan, Hong Kong, and Korea. Culme-Seymour has 22 years of logistics experience with airlines, express couriers, and major post companies in Singapore, Zurich, and London. He was most recently owner of Fischer Road Express, a private company specializing in life-science logistics.
Source: Marken
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
